Eywa Biotech founder and CEO Victoria Costa Paz explains why bringing psychedelic medicine into mainstream mental health care requires far more than producing pharmaceutical-grade psilocybin. She shares how Eywa is combining biosynthesis, patient tracking, professional education, and treatment infrastructure to build a system around a new model of mental health care.

Mike Karadimas on Turning Family History Into a Crime Thriller
15:14

Edward McGeorge Went All In and Built an RV Empire Against the Odds
54:15

Anna Tobin on Building the Financial Infrastructure for Global Startups
13:28